<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:26:38Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:156599" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:156599</identifier><datestamp>2003-06-05</datestamp><setSpec>bmcgene</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://dtd.nlm.nih.gov/ns/archiving/2.3/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://dtd.nlm.nih.gov/ns/archiving/2.3/ https://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Genet</journal-id>
      <journal-title>BMC Genetics</journal-title>
      <issn pub-type="epub">1471-2156</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC156599</article-id>
      <article-id pub-id-type="pmcid">PMC156599</article-id>
      <article-id pub-id-type="pmc-uid">156599</article-id>
      <article-id pub-id-type="pmid">12697062</article-id>
      <article-id pub-id-type="publisher-id">1471-2156-4-5</article-id>
      <article-id pub-id-type="pmid">12697062</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2156-4-5</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Characterization of rabbit myocilin: Implications for human myocilin glycosylation and signal peptide usage</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" contrib-type="author">
          <name>
            <surname>Shepard</surname>
            <given-names>Allan R</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>allan.shepard@alconlabs.com</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Jacobson</surname>
            <given-names>Nasreen</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>nasreen.jacobson@alconlabs.com</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Sui</surname>
            <given-names>Ruifang</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>hrfsui@yahoo.com</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Steely</surname>
            <given-names>H Thomas</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>thomas.steely@alconlabs.com</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Lotery</surname>
            <given-names>Andrew J</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>andrew-lotery@uiowa.edu</email>
        </contrib>
        <contrib id="A6" contrib-type="author">
          <name>
            <surname>Stone</surname>
            <given-names>Edwin M</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>edwin-stone@uiowa.edu</email>
        </contrib>
        <contrib id="A7" corresp="yes" contrib-type="author">
          <name>
            <surname>Clark</surname>
            <given-names>Abbot F</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>abe.clark@alconlabs.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Alcon Research, Ltd., 6201 South Freeway, Fort Worth, TX 76134, USA</aff>
      <aff id="I2"><label>2</label>Department of Ophthalmology, The University of Iowa College of Medicine, 200 Hawkins Drive, Iowa City, Iowa 52242, USA</aff>
      <pub-date pub-type="collection">
        <year>2003</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>2</day>
        <month>4</month>
        <year>2003</year>
      </pub-date>
      <volume>4</volume>
      <fpage>5</fpage>
      <lpage>5</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2156/4/5"/>
      <history>
        <date date-type="received">
          <day>6</day>
          <month>12</month>
          <year>2002</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>4</month>
          <year>2003</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2003 Shepard et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement>
        <copyright-year>2003</copyright-year>
        <copyright-holder>Shepard et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Mutations in the gene encoding human myocilin (<italic>MYOC</italic>) have been shown to cause juvenile- and adult-onset glaucoma. In addition, myocilin has been associated with glucocorticoid-induced ocular hypertension and steroid-induced glaucoma. To better understand the role myocilin plays in steroid-induced glaucoma and open-angle glaucoma, we examined rabbit myocilin for use in the rabbit animal model of steroid-induced glaucoma.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>We have cloned the rabbit ortholog of human <italic>MYOC</italic>. Rabbit <italic>MYOC </italic>consists of three exons and an open reading frame encoding a 490 amino acid, 54,882-Da protein, which is 14 amino acids shorter at the N-terminus than human myocilin but 84% identical overall. Rabbit myocilin migrates as a single electrophoretic band, vs. double-banded human myocilin, by SDS-PAGE/immunoblot analysis. We determined that the differential migration exhibited is due to an N-glycosylation site that is present in human (Asn57), monkey and mouse myocilin but absent in rabbit (Ser43), rat and bovine myocilin. Rabbit myocilin is secreted <italic>in vitro </italic>in trabecular meshwork cell culture and in vivo in aqueous humor. Secretion of human myocilin is shown to be dependent on the signal peptide and independent of the extra 14 amino acids not found in rabbit myocilin. Many of the amino acids in myocilin that are mutated in glaucoma patients are conserved across species.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>We have cloned the rabbit <italic>MYOC </italic>cDNA and determined that rabbit myocilin is secreted but not N-linked glycosylated. Knowledge of the rabbit <italic>MYOC </italic>cDNA sequence will facilitate future studies in the rabbit animal model examining the role of myocilin in steroid-induced glaucoma and the gain-of-function hypothesis in open-angle glaucoma.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Mutations in <italic>MYOC </italic>have been shown to be causative for primary open angle glaucoma (POAG) [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. Glucocorticoids have been implicated in ocular hypertension and glaucoma due to increased plasma cortisol levels [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>] and altered cortisol metabolism [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>] in POAG patients and from the increased risk of developing POAG in steroid-responsive patients [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. Myocilin has been shown to be upregulated in glucocorticoid-treated human trabecular meshwork (TM) cells [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>], and there is variable evidence for increased <italic>MYOC </italic>expression in glaucomatous individuals [<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B14">14</xref>]. In addition, glaucoma patients have a higher chance of responding to steroids than non-glaucomatous individuals. However, an extensive study of mutations in the proximal promoter and coding region of <italic>MYOC </italic>found no sequence polymorphisms associated with steroid responsiveness [<xref ref-type="bibr" rid="B15">15</xref>].</p>
      <p>Myocilin has been shown to be secreted both in human TM cell cultures and in vivo in aqueous humor (AH) [<xref ref-type="bibr" rid="B12">12</xref>]. Glaucomatous mutations, however, alter myocilin Triton solubility [<xref ref-type="bibr" rid="B16">16</xref>] and prevent myocilin from being secreted [<xref ref-type="bibr" rid="B12">12</xref>]. The glycosylation status of myocilin is somewhat controversial. Several groups have shown that myocilin is glycosylated [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B21">21</xref>] whereas one group suggests that myocilin is not glycosylated [<xref ref-type="bibr" rid="B22">22</xref>]. In our hands, both an N-linked glycosylated (â57-kDa) and unglycosylated (â55-kDa) form of myocilin is detected in TM cell culture media [<xref ref-type="bibr" rid="B17">17</xref>] and aqueous humor [<xref ref-type="bibr" rid="B12">12</xref>]. The basis for both secretion and N-linked glycosylation of myocilin is part of the focus of this paper.</p>
      <p>Rabbits have been successfully used as a model of glucocorticoid-induced ocular hypertension [<xref ref-type="bibr" rid="B23">23</xref>-<xref ref-type="bibr" rid="B27">27</xref>]. In order to study the association of <italic>MYOC </italic>gene expression with steroid-induced ocular hypertension, it will be helpful to know the sequence of rabbit myocilin. We report here the cloning, sequence comparison and expression analysis of rabbit <italic>MYOC</italic>. We show that an N-terminal signal peptide is necessary for myocilin secretion and we identify the N-linked glycosylation site found in human but not rabbit myocilin.</p>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Characterization of Rabbit <italic>MYOC</italic></title>
        <p>We have cloned a 2-kb cDNA for rabbit <italic>MYOC </italic>that encodes a 490 amino acid, 55-kDa protein with a calculated pI of 5.25 (Fig. <xref ref-type="fig" rid="F1">1</xref>). Rabbit myocilin amino acid sequence is 84% identical to human myocilin [<xref ref-type="bibr" rid="B28">28</xref>] and highly homologous across species (Table <xref ref-type="table" rid="T2">2</xref>) with an overall 64% homology. Rabbit myocilin is 14 amino acids shorter at the N-terminus than human myocilin and the same length as monkey [<xref ref-type="bibr" rid="B15">15</xref>], mouse [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>], and bovine [<xref ref-type="bibr" rid="B31">31</xref>] myocilin (Fig. <xref ref-type="fig" rid="F2">2</xref>). As in all myocilin orthologs cloned to date, rabbit myocilin contains a leucine zipper motif (aa 103 to 152) (Fig. <xref ref-type="fig" rid="F2">2</xref>). A potential peroxisomal targeting signal is encoded on the C-terminus (SKI, aa 488â490). Unlike human, monkey and mouse myoclin, rabbit myocilin does not contain a consensus N-linked glycosylation site (N-X-S/T; human, aa 57â59; monkey, aa 43â45; mouse, aa 43â45) (Fig. <xref ref-type="fig" rid="F2">2</xref>). The nucleotide sequence for rabbit <italic>MYOC </italic>reported in this manuscript has been submitted to GenBank (AY191317).</p>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p><bold>Rabbit <italic>MYOC </italic>Sequence</bold>. Nucleotide and deduced amino acid sequence of rabbit <italic>MYOC </italic>cDNA. Open reading frame nucleotides are shown in bold. Encoded amino acids are shown by single letter code and the stop codon is indicated with an asterisk. Numbers to the left indicate nucleotide position. The consensus polyadenylation signal (AATAAA) is underlined.</p>
          </caption>
          <graphic xlink:href="1471-2156-4-5-1"/>
        </fig>
        <fig position="float" id="F2">
          <label>Figure 2</label>
          <caption>
            <p><bold>Alignment of myocilin orthologs</bold>. Alignment of rabbit, human, monkey, mouse, rat, and bovine myocilin amino acid sequences. Identical amino acids are shaded and missing amino acids are indicated with a dash. The 14 amino acid deletion in human <italic>MYOC </italic>plasmid pcDNA3.hMYOC.ÎN14 is underlined. The putative myocilin signal peptide is boxed. Location of the predicted N-linked glycosylation site (human myocilin Asn57) is indicated with a 'n'. Locations of predicted O-linked glycosylation sites are marked with an 'o'. The leucine zipper motif is marked by dots. Disease-causing mutations identified based on experimental data and statistical arguments with glaucoma family pedigrees and documented in the Human Gene Mutation Database <ext-link ext-link-type="uri" xlink:href="http://uwcmml1s.uwcm.ac.uk/uwcm/mg/search/5584221.html"/> are indicated with a 'x'. GenBank accession numbers are as follows: rabbit, AY191317; human, NM_000261; monkey, AY190128, AY190129, AY190130; mouse, AF039869; rat, AF093567; bovine, AB027758.</p>
          </caption>
          <graphic xlink:href="1471-2156-4-5-2"/>
        </fig>
        <table-wrap position="float" id="T1">
          <label>Table 1</label>
          <caption>
            <p>Rabbit and Human MYOC primers used for PCR and Cloning</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <td align="left">
                  <bold>Primer</bold>
                </td>
                <td align="left">
                  <bold>Sequence</bold>
                </td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Exon1F*</td>
                <td align="left">5'-CAGTCCCAATGAATCCAGC-3'</td>
              </tr>
              <tr>
                <td align="left">Exon1R</td>
                <td align="left">5'-CTCTCTGGTTTGGGTTTCCA-3'</td>
              </tr>
              <tr>
                <td align="left">5'RACE</td>
                <td align="left">5'-CAGCTCCTTCTGCAATTCCTCCT-3'</td>
              </tr>
              <tr>
                <td align="left">5'RACEnest</td>
                <td align="left">5'-CTTCTGCAATTCCTCCTGGATCTC-3'</td>
              </tr>
              <tr>
                <td align="left">3'RACE</td>
                <td align="left">5'-CATCCAGGACCTCCAGAGAGACAG-3'</td>
              </tr>
              <tr>
                <td align="left">3'RACEnest</td>
                <td align="left">5'-ACCTCCAGAGAGACAGTACCC-3'</td>
              </tr>
              <tr>
                <td align="left">P355F</td>
                <td align="left">5'-CTTCTCAATGGAATTTGGACACTT-3'</td>
              </tr>
              <tr>
                <td align="left">P356F</td>
                <td align="left">5'-GATGTGGGGAACTAGTTTGGGTAG-3'</td>
              </tr>
              <tr>
                <td align="left">P356R</td>
                <td align="left">5'-AGT<underline>GCGGCCGC</underline>TTAAATCTTGGACAGCTTGATGTC-3'</td>
              </tr>
              <tr>
                <td align="left">P357F</td>
                <td align="left">5'-GCA<underline>GGATCC</underline>CCAAGGTTTTTCCCTGCACATTGCTGC-3'; BamH1 underlined</td>
              </tr>
              <tr>
                <td align="left">P365R</td>
                <td align="left">5'-AGT<underline>GCGGCCGC</underline>GTTGTCTCCCTCTTCACCC-3'; Not1 underlined</td>
              </tr>
              <tr>
                <td align="left">P368R</td>
                <td align="left">5'-pCTTCCCTGGAGCCTGCAGGCACAT-3'; p indicates phosphorylation</td>
              </tr>
              <tr>
                <td align="left">P370R</td>
                <td align="left">5'-pCGTTGTCTCCCTCTTCACCCCTGG-3'; p indicates phosphorylation</td>
              </tr>
              <tr>
                <td align="left">P235</td>
                <td align="left">5'-CCC<underline>AAGCTT</underline>ATGCCAGCTGTCCAGCTGCT-3'; HindIII underlined</td>
              </tr>
              <tr>
                <td align="left">P236</td>
                <td align="left">5'-CCC<underline>AAGCTT</underline>ATGAGGACAGCTCAGCTCAGGAAG-3'; HindIII underlined</td>
              </tr>
              <tr>
                <td align="left">P237</td>
                <td align="left">5'-CCG<underline>CCTCAGG</underline>GTGCCCAGCT-3'; Bsu36I underlined</td>
              </tr>
              <tr>
                <td align="left">P316F</td>
                <td align="left">5'-GGCCAGTCCCA<underline>G</underline>TGAATCCAGCTGCCC-3'; Mutation underlined</td>
              </tr>
              <tr>
                <td align="left">P316R</td>
                <td align="left">5'-GGGCAGCTGGATTCA<underline>C</underline>TGGGACTGGCC-3'; Mutation underlined</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>* Note: F, forward orientation; R, reverse orientation</p>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap position="float" id="T2">
          <label>Table 2</label>
          <caption>
            <p>Myocilin ortholog identity comparison</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <td/>
                <td align="center">Human</td>
                <td align="center">Rabbit</td>
                <td align="center">Monkey</td>
                <td align="center">Mouse</td>
                <td align="center">Rat</td>
                <td align="center">Bovine</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Human</td>
                <td align="center">100</td>
                <td align="center">84</td>
                <td align="center">94</td>
                <td align="center">80</td>
                <td align="center">81</td>
                <td align="center">80</td>
              </tr>
              <tr>
                <td align="left">Rabbit</td>
                <td/>
                <td align="center">100</td>
                <td align="center">86</td>
                <td align="center">83</td>
                <td align="center">80</td>
                <td align="center">82</td>
              </tr>
              <tr>
                <td align="left">Monkey</td>
                <td/>
                <td/>
                <td align="center">100</td>
                <td align="center">82</td>
                <td align="center">79</td>
                <td align="center">82</td>
              </tr>
              <tr>
                <td align="left">Mouse</td>
                <td/>
                <td/>
                <td/>
                <td align="center">100</td>
                <td align="center">91</td>
                <td align="center">79</td>
              </tr>
              <tr>
                <td align="left">Rat</td>
                <td/>
                <td/>
                <td/>
                <td/>
                <td align="center">100</td>
                <td align="center">77</td>
              </tr>
              <tr>
                <td align="left">Bovine</td>
                <td/>
                <td/>
                <td/>
                <td/>
                <td/>
                <td align="center">100</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec>
        <title>Secretion of Rabbit <italic>MYOC</italic></title>
        <p>Rabbit, monkey, mouse and bovine myocilin open reading frames begin at amino acid 15 relative to human myocilin. The function, if any, of the extra N-terminal 14 aa encoded by human myocilin is not presently known. Rat myocilin also contains an extra 13 aa N-terminal sequence [<xref ref-type="bibr" rid="B32">32</xref>]. To determine if rabbit myocilin is secreted despite the absence of the additional human-like N-terminal 14 aa, we examined rabbit aqueous humor. We were able to detect myocilin in rabbit aqueous humor (Fig. <xref ref-type="fig" rid="F3">3A</xref>). This suggests that the human N-terminal 14 aa is dispensible for secretion and that the rabbit myocilin sequence is sufficient to direct secretion.</p>
        <fig position="float" id="F3">
          <label>Figure 3</label>
          <caption>
            <p><bold>Rabbit <italic>MYOC </italic>expression</bold>. Western immunoblot analysis of myocilin in (<bold>A</bold>) rabbit, human, and monkey aqueous humor samples treated with (+) or without (-) glycosidases and in (<bold>B</bold>) GTM66 cells transfected with expression vectors encoding wild-type human <italic>MYOC </italic>(WT), N-terminal 14 (ÎN14) or 32 (ÎN32) aa deleted human <italic>MYOC</italic>, or N57S mutated human <italic>MYOC</italic>. I, intracellular myocilin present in the cell lysate; E, extracellular myocilin secreted into the medium. 57/55-kDa myocilin doublet is indicated with arrows.</p>
          </caption>
          <graphic xlink:href="1471-2156-4-5-3"/>
        </fig>
        <p>Next we created a human myocilin expression construct where the N-terminal 14aa were deleted (pcDNA3.hMYOC.ÎN14) forcing translation to begin at the second methionine codon (Fig. <xref ref-type="fig" rid="F2">2</xref>). GTM66 cells were chosen for this study based on their ability to grow and transfect well and are a glaucomatous TM cell line derived from a 92-year-old female donor [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. Transfection of GTM66 cells with the N-terminal deletion mutant resulted in a distribution pattern similar to wild-type human myocilin (Fig. <xref ref-type="fig" rid="F3">3B</xref>). The fact that we see no discernable difference in the relative mobility between transfected human wild-type myocilin and 14 amino acid amino-terminal deleted myocilin (Fig. <xref ref-type="fig" rid="F3">3B</xref>) and human vs. monkey myocilin in AH (Fig. <xref ref-type="fig" rid="F3">3A</xref>) may be due to the use of small format gels or possibly to the usage of the second N-terminal methionine by the cell for synthesizing human myocilin, making human and monkey molecular weights comparable.</p>
        <p>Nonetheless, an N-terminal signal peptide is likely necessary for directing synthesis of myocilin, via the ER-Golgi pathway, for secretion outside the cell. To determine what actually constitutes the signal sequence for myocilin, we conducted an analysis of signal peptide cleavage sites using the Center for Biological Sequence Analysis SignalP v1.1 Database <ext-link ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/SignalP/"/>. A signal peptide cleavage site was predicted to exist between rabbit aa 18 and 19 (human aa 32 and 33) [<xref ref-type="bibr" rid="B33">33</xref>]. We directly tested the importance of the signal peptide in myocilin secretion by replacing the first 32 aa of human myocilin with a single methionine (pcDNA3.hMYOC.ÎN32). Transfection of GTM66 cells with pcDNA3.hMYOC.ÎN32 resulted in intracellular but not extracellular myocilin distribution (Fig. <xref ref-type="fig" rid="F3">3B</xref>). This is the result expected if the signal peptide were necessary for secretion. This suggests that the first 18 aa of rabbit myocilin may function as a signal peptide and are necessary for myocilin secretion.</p>
      </sec>
      <sec>
        <title>Myocilin Glycosylation</title>
        <p>Human myocilin has been shown to migrate as a 55/57-kDa doublet by SDS-PAGE/immunoblot analysis [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. The modification accounting for this molecular weight difference is hypothesized to be due to differential glycosylation. N-linked glycosylation sites were predicted using the Center for Biological Sequence Analysis NetNGlyc 1.0 Prediction Server <ext-link ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/NetNGlyc/"/>. Human, monkey and mouse myocilin contain a consensus asparagine (N)-linked glycosylation site (NES) near the N-terminus, whereas rabbit, rat and bovine code for SES at this position (Fig. <xref ref-type="fig" rid="F2">2</xref>). Having a serine present at this position would eliminate N-linked glycosylation and would be predicted to result in a difference in relative gel mobility between human/monkey and rabbit myocilin.</p>
        <p>To test this hypothesis we analyzed human, monkey, and rabbit AH myocilin side-by-side in SDS-PAGE/immunoblots. The anti-human myocilin antibody 129 used in these studies (generated to human amino acids 156â171[<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B17">17</xref>]) cross-reacts with rabbit and monkey myocilin. With human and monkey myocilin we see a clear doublet, whereas rabbit myocilin migrates as a single band with the same relative mobility as the lower band of human and monkey myocilin (Fig. <xref ref-type="fig" rid="F3">3A</xref>), suggesting that the asparagine vs. serine amino acid difference is responsible for the differential glycosylation.</p>
        <p>To directly test this theory, we mutated human myocilin amino acid 57 from Asn to Ser, as found in rabbit myocilin. Media and cell lysate from transfected GTM66 cells contained a single immunoreactive myocilin band that migrated with the same relative mobility as the lower wt myocilin band (Fig. <xref ref-type="fig" rid="F3">3B</xref>). This suggests that the 55/57-kDa human myocilin doublet is due to differential glycosylation and that the site of N-linked glycosylation on human myocilin is Asn 57.</p>
        <p>To determine the effects of deglycosylation on myocilin, we treated human, monkey, and rabbit AH with a cocktail of glycosidases (N- and O-linked). Our results show that the upper band of human and monkey myocilin is eliminated whereas the lower band remains unaltered (Fig. <xref ref-type="fig" rid="F3">3A</xref>). This indicates that the upper human and monkey myocilin band is glycosylated. In addition, the single rabbit myocilin band shifted downward slightly with deglycosylation. This may be due to removal of O-linked glycosylation.</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>We report the cloning and characterization of rabbit myocilin. Rabbit myocilin is highly similar to the other myocilin orthologs (Table <xref ref-type="table" rid="T2">2</xref>) and contains a leucine zipper motif encoded by exon 1 (Fig. <xref ref-type="fig" rid="F2">2</xref>). This conservation likely reflects the importance of the leucine zipper motif in directing protein-protein interactions [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. Many amino acid mutations encoded in the olfactomedin homology domain of exon 3 that are known to cause glaucoma in humans are also conserved in rabbit myocilin. In fact, all 31 amino acids (34 missense/nonsense mutations total) for human myocilin documented in the Human Gene Mutation Database <ext-link ext-link-type="uri" xlink:href="http://uwcmml1s.uwcm.ac.uk/uwcm/mg/search/5584221.html"/> to cause glaucoma are conserved in rabbit myocilin (Fig <xref ref-type="fig" rid="F2">2</xref>).</p>
      <p>Myocilin has been shown to be secreted <italic>in vitro </italic>and <italic>in vivo </italic>by several investigators [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B36">36</xref>-<xref ref-type="bibr" rid="B38">38</xref>]. Secreted proteins typically contain a 16â30 aa signal sequence on their N-terminus which directs the completion of protein synthesis across the ER membrane. A signal peptidase cleaves the signal sequence and the trimmed protein is shuttled through the Golgi for secretion. We demonstrate the functionality of the N-terminal signal peptide in directing myocilin secretion. Deletion of the predicted N-terminal signal peptide results in loss of secretion but not intracellular appearance (Fig. <xref ref-type="fig" rid="F3">3B</xref>).</p>
      <p>There are conflicting reports on whether myocilin is glycosylated. Differential glycosylation of myocilin has been shown in this report and by others [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>] to account for the appearance of a 55/57-kDa doublet by Western immunoblot analysis. In contrast, Huang et al. [<xref ref-type="bibr" rid="B22">22</xref>] report that myocilin is not glycosylated. This discrepancy may be due to technical reasons. Huang et al. did not resolve the 55/57-kDa doublet using their SDS-PAGE system and only detected a 57-kDa human myocilin band, so any deglycosylation (PNGase F, NANase II, and O-Glycosidase) occurring would be difficult to resolve. A positive control was not reported in their deglycosylation experiment, so their conclusion that myocilin is not glycosylated may simply be due to inactive glycosidase. The lack of glycosylation seen in the <italic>in vitro </italic>canine pancreatic microsomal membrane translation experiment may again be due to poor 55/57-kDa myocilin doublet resolution or the inability of this artificial system to faithfully glycosylate myocilin. However, Caballero et al. was able to detect deglycosylation affects using similar methodology [<xref ref-type="bibr" rid="B20">20</xref>].</p>
      <p>Nguyen et al. [<xref ref-type="bibr" rid="B10">10</xref>] identified a 66-kDa band as the glycosylated and major extracellular form of human myocilin and not the upper band in the 55/57-kDa doublet. These authors claim that the lower band of the unglycosylated 55/57-kDa doublet is due to cleavage of the N-terminal 32 amino acid signal peptide. In our hands, we do not see a 66-kDa band on our anti-myocilin Western blots, even using human aqueous humor as a source of myocilin. We provide evidence that the upper band of the 55/57-kDa doublet is the glycosylated form of myocilin (Fig. <xref ref-type="fig" rid="F3">3A</xref>). Another group has also reported the 66-kDa band using an anti-myocilin antibody different from the Nguyen et al. antibody [<xref ref-type="bibr" rid="B14">14</xref>]. The reason for the appearance of this 66-kDa is unclear, but may be due to cross-reaction of the primary or secondary antibody with another protein such as albumin, which has a molecular weight of 65-kDa (GenPept accession # NP_000468). To date, protein sequence data identifying the 66-kDa band as myocilin has not been reported.</p>
      <p>Human myocilin Asn57 is part of an N-linked glycosylation consensus (NES) and is the only residue on myocilin predicted to be N-glycosylated. We provide both site-directed mutagenesis (Fig. <xref ref-type="fig" rid="F3">3B</xref>) and deglycosylation (Fig. <xref ref-type="fig" rid="F3">3A</xref>) evidence that the upper band of the 55/57-kDa human and monkey myocilin doublet is the glycosylated form. The increase in mobility of rabbit myocilin with deglycosylation (Fig. <xref ref-type="fig" rid="F3">3A</xref>) is likely due to removal of O-linked glycosylation. Analysis of O-linked glycosylation by the CBS NetOGlyc 2.0 Prediction Server <ext-link ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/NetOGlyc/"/> identified two unique (rabbit Thr93 and Thr267) and three common (rabbit Thr66, Thr263, and Ser45) O-linked glycosylation sites in rabbit vs. human/monkey myocilin. The additional O-linked glycosylation sites in rabbit may be responsible for the mobility shift seen in the deglycosylation experiment and the relative diffusiveness of the rabbit myocilin band.</p>
      <p>A naturally occuring Asn57Asp polymorphism may be associated with JOAG [<xref ref-type="bibr" rid="B39">39</xref>] which, if truly disease-associated, would suggest the functional importance of N-linked glycosylation. N-linked glycosylation is known to confer stability on many extracellular proteins [<xref ref-type="bibr" rid="B40">40</xref>]. Myocilin is similar to fibronectin (an extracellular matrix protein) in that both a glycosylated and unglycosylated form is secreted from the cell. The unglycosylated form of fibronectin is more susceptible to proteolytic degradation than the glycosylated form [<xref ref-type="bibr" rid="B41">41</xref>]. It will be interesting to determine why two forms of myocilin are secreted in humans and what functionality, if any, N-linked glycosylation imparts on human vs. rabbit myocilin.</p>
      <p>It is still unknown how myocilin functions normally and pathophysiologically. However, recent evidence suggests that disease-causing myocilin mutations are gain of function. Disease-causing myocilin mutants are less soluble in Triton [<xref ref-type="bibr" rid="B16">16</xref>] and are retained by the cell [<xref ref-type="bibr" rid="B12">12</xref>]. Other studies have shown that a truncated form of myocilin does not get secreted [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>] and that mouse <italic>MYOC </italic>knockouts are without discernable phenotype [<xref ref-type="bibr" rid="B42">42</xref>]. Furthermore, a human hemizygous individual containing an interstitial deletion of chromosome 1, which encodes <italic>MYOC</italic>, was without evidence of glaucoma [<xref ref-type="bibr" rid="B43">43</xref>] and another patient homozygous for a severly truncated form of myocilin had no evidence of glaucoma [<xref ref-type="bibr" rid="B44">44</xref>] or other discernable phenotypes. This suggests that <italic>MYOC </italic>haploinsufficiency is not causative for glaucoma and that myocilin may even be dispensable or redundant in normal human development or only important when ocular stress occurs.</p>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>Rabbit <italic>MYOC </italic>encodes a protein highly similar to human <italic>MYOC</italic>. Rabbit myocilin is secreted and is detected in rabbit aqueous humor. Secretion of myocilin is dependent on an 18 amino acid N-terminal signal peptide. Unlike human and monkey AH myocilin, rabbit myocilin does not undergo canonical N-linked glycosylation due to the substitution of a serine in the analogous human N-linked glycosylation site (N57). Rabbits may provide an in vivo system for modeling some aspects of glaucoma, such as steroid induced ocular hypertension [<xref ref-type="bibr" rid="B23">23</xref>-<xref ref-type="bibr" rid="B27">27</xref>] and the gain-of-function hypothesis in POAG [<xref ref-type="bibr" rid="B42">42</xref>].</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Cloning of rabbit <italic>MYOC</italic></title>
        <p>Total RNA was extracted from rabbit eye and heart tissue (Pel Freez) using Trizol (Invitrogen). Primers derived from conserved regions of human and mouse <italic>MYOC </italic>(Table <xref ref-type="table" rid="T1">1</xref>, primers Exon1F/Exon1R) were used to amplify a 250-bp section of rabbit <italic>MYOC </italic>exon 1 (Fig. <xref ref-type="fig" rid="F1">1</xref>, nts 184â433) by PCR as described [<xref ref-type="bibr" rid="B15">15</xref>]. 5' and 3' RACE (Invitrogen) was used to obtain the 5' and 3' cDNA ends. Essentially, two micrograms rabbit total RNA was converted into first strand cDNA with adapter primer and Superscript II reverse transcriptase. Primary and nested 5' and 3' RACE primers were all designed within the 250-bp region of rabbit <italic>MYOC </italic>exon 1 (Table <xref ref-type="table" rid="T1">1</xref>). PCR products were subcloned into TOPOâ¢ TA cloning vectors (Invitrogen) and subjected to cycle sequencing (Division of Molecular Transport, Department of Internal Medicine, University of Texas Southwestern Medical Center).</p>
        <p>Due to difficulties in amplifying the rabbit <italic>MYOC </italic>coding region from cDNA, we pieced together the entire contiguous open-reading frame using rabbit genomic DNA (Clontech; New Zealand White) as a template with a multi-step PCR/ligation process. In the first step, exons 1 and 2 were amplified from genomic DNA with primers P357F/P368R to exon 1 and P355F/P365R to exon 2. Primers P368R and P355F directly abut each other at the exon 1/2 boundary. PCR amplification was performed in a 50 ul volume with the PfuTurbo Hotstart DNA Polymerase system (Stratagene) and included 0.2 mM dNTPs, 100 ng each primer, 2.5 units PfuTurbo DNA polymerase, 100 ng genomic DNA, and 1X cloned Pfu DNA polymerase reaction buffer. Cycling conditions consisted of 2 min at 95Â°C followed by 15 cycles at 95Â°C 30 sec, 60Â°C 30 sec, and 72Â°C 1 min in a Perkin Elmer 9700 thermalcycler. PCR products were restriction digested with BamH1 (exon 1) or Not1 (exon 2), purified from an agarose gel by Qiaquick extraction (Qiagen), and simultaneously subcloned into a BamH1/Not1 digested pcDNA3 (Invitrogen) vector to create a directional clone of rabbit <italic>MYOC </italic>exons 1 and 2 spliced together (pcDNA3.RbMYOCex1â2). Sequence integrity of the cloned DNA was verified by cycle sequencing and restriction digestion.</p>
        <p>Exons 1â2 of plasmid pcDNA3.RbMYOCex1â2 was then amplified with primers P357F/P370R and exon 3 was amplified from genomic DNA with primers P356F/P356R. Primers P370R and P356F directly abut each other at the exon 2/3 boundary. PCR was performed as above and PCR products digested with BamH1 (exons 1â2) or Not1 (exon 3) and processed/cloned as above to create a directional clone of rabbit <italic>MYOC </italic>exons 1â2 and 3 spliced together (pcDNA3.RbMYOCex1â3). Plasmid DNA integrity was confirmed by restriction analysis and cycle sequencing.</p>
      </sec>
      <sec>
        <title>Sequence analysis and comparison</title>
        <p>Alignment of DNA sequence contigs, protein sequences, and plasmid DNA sequence/construction was performed with Vector NTI 7.1 software (Informax).</p>
      </sec>
      <sec>
        <title>Construction of human <italic>MYOC </italic>mutants</title>
        <p>Human <italic>MYOC </italic>cDNA was cloned into the pcDNA3 (Invitrogen) mammalian expression vector as described [<xref ref-type="bibr" rid="B12">12</xref>]. Human myocilin signal sequence deletions were generated by PCR. A 5' PCR primer, with a 5' HindIII site added, was designed to eliminate either the first 42- (P235; ÎN14) or 96- (P236; ÎN32) nucleotides of the human <italic>MYOC </italic>ORF and used in conjunction with a 3' PCR primer (P237) covering the internal Bsu36I restriction site (Table <xref ref-type="table" rid="T1">1</xref>). Primer P236 replaced the first 32 amino acid codons with a methionine codon. PCR and processing were as described above with the exception that the 5' human <italic>MYOC </italic>deletion products were cloned into a HindIII/Bsu36I digested pcDNA3.hMYOC wild-type vector.</p>
        <p>Substitution of human myocilin Asn 57 with Ser was accomplished using the QuickChange XL Site-Directed Mutagenesis kit (Stratagene) according to the manufacturer's instructions. Primer pair P316F/P316R was designed to replace the Asn57 A<underline>A</underline>T codon with the Ser A<underline>G</underline>T codon (Table <xref ref-type="table" rid="T1">1</xref>). The entire mutated cDNA was sequence verified and subcloned into a fresh pcDNA3 vector to avoid non-specific Taq DNA polymerase errors. Proper cloning was verified by restriction digestion analysis and sequencing.</p>
      </sec>
      <sec>
        <title>Cell culture and transfection</title>
        <p>GTM66 cells were derived from a 92-year old woman with glaucoma and were cultured in low glucose DMEM (HyClone Laboratories) with 10% FBS (HyClone Laboratories) and antibiotics (Invitrogen) as described [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. Cells were transfected with Lipofectamine 2000 reagent according to the manufacturers recommendations (Invitrogen). Transfected plasmid DNA included wild-type human <italic>MYOC </italic>(pcDNA3.hMYOC; [<xref ref-type="bibr" rid="B12">12</xref>]), wild-type rabbit <italic>MYOC </italic>(pcDNA3.RbMYOC.ex1â3), N-terminal 14 amino acid deleted human <italic>MYOC </italic>(pcDNA3.hMYOC.ÎN14), N-terminal 32 amino acid deleted human <italic>MYOC </italic>(pcDNA3.hMYOC.ÎN32), or N57S human <italic>MYOC </italic>(pcDNA3.hMYOC.N57S). Cells were switched to serum-free media 24 h post-transfection and media or cell lysates were collected after overnight incubation. Equivalent cell lysate protein amounts (5 Î¼g) were loaded for reduced SDS-PAGE analysis (Fig. <xref ref-type="fig" rid="F3">3B</xref>). Cell media was not concentrated and was loaded at 16 ul per lane in Fig. <xref ref-type="fig" rid="F3">3B</xref>.</p>
      </sec>
      <sec>
        <title>Aqueous humor samples</title>
        <p>All experimental animals used in this study were treated in compliance with the Association for Research in Vision and Ophthalmology (ARVO) resolution on the use of animals in research. Rabbit aqueous humor samples (135â190 Î¼l) were taken from anesthetized New Zealand Albino (NZA) rabbits and mixed with protease inhibitor cocktail (Complete; Roche) to prevent myocilin degradation. Human aqueous humor samples were obtained as previously described [<xref ref-type="bibr" rid="B12">12</xref>]. The equivalent of 4 Î¼l AH was used per lane in Fig. <xref ref-type="fig" rid="F3">3A</xref>.</p>
      </sec>
      <sec>
        <title>Immunoblot analysis</title>
        <p>Cells were rinsed with PBS and solubilized in a commercial mammalian extraction buffer (M-Perâ¢; Pierce, Rockford, IL) supplemented with a protease inhibitor cocktail (Complete; Roche) followed by centrifugation at 12,000 Ã g for 5 min. Protein concentration of the supernatant was determined with Coomassie Plus Protein Assay Reagent (Pierce). Cell extracts were stored at -20Â°C.</p>
        <p>Aqueous humor, cell media, and cell extracts were analyzed using pre-cast Criterion 7.5% Tris-HCl polyacrylamide gels (Bio-Rad) and the Bio-Rad electrophoresis system (Bio-Rad). Proteins were electroblotted to Hybond-P PVDF membranes (Amersham Pharmacia Biotech), blocked with gelatin, and probed with affinity purified rabbit anti-human myocilin antibody 129 (AB129; generated to human myocilin amino acids 156â171) [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B17">17</xref>] and an anti-rabbit IgG secondary antibody (Amersham). Immunoreactivity was detected with the ECL Plus detection system (Amersham). Blots were exposed to BioMax MR film (Eastman Kodak) and scanned with a HP ScanJet 7400 c scanner (Hewlett Packard).</p>
      </sec>
      <sec>
        <title>Deglycosylation of aqueous humor myocilin</title>
        <p>Aqueous humor from human, monkey and rabbit was subjected to deglycosylation with a mixture of N-linked and O-linked glycosidases (PNGase F, sialidase, Î²-galactosidase, glucosaminidase and O-glycosidase) using the Enzymatic CarboRelease Kit according to the manufacturers instructions (QA-Bio). AH samples in buffer were boiled for 5 min in the presence of denaturant followed by incubation for 3 hr at 37Â°C with the glycosidase mixture. NuPAGE sample buffer (Invitrogen) was added to stop the reaction, samples were heated for 10 min at 70Â°C and subjected to NuPAGE electrophoresis on 10% NuPAGE gels (Invitrogen). Samples were transferred to PVDF, immunoblotted versus AB129, and developed using ECL Plus.</p>
      </sec>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>AS carried out the clone isolation and characterization, sequence comparison, plasmid construction, and drafted the manuscript. NJ carried out the cell culture, transfections and immunoblot analyses. RS generated preliminary sequence data for rabbit <italic>MYOC </italic>and a preliminary manuscript draft. TS provided computer analysis/modeling of myocilin. AL oversaw the work of RS. ES oversaw the work of AL and RS. AC conceived of the study, helped draft the manuscript, and oversaw the work of AS, NJ, and TS.</p>
      <p>All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>This work was supported by NIH grant RO1-EY-10564 (ES) and Alcon Research, Ltd. ES is an Investigator of the Howard Hughes Medical Institute.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stone</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Fingert</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Alward</surname>
              <given-names>WLM</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Polansky</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Sunden</surname>
              <given-names>SLF</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Nystuen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nichols</surname>
              <given-names>BE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of a gene that causes primary open angle glaucoma [see comments]</article-title>
          <source>Science</source>
          <year>1997</year>
          <volume>275</volume>
          <fpage>668</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">9005853</pub-id>
          <pub-id pub-id-type="doi">10.1126/science.275.5300.668</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fingert</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Heon</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Liebmann</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Craig</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Rait</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kawase</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hoh</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Buys</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Dickinson</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Analysis of myocilin mutations in 1703 glaucoma patients from five different populations</article-title>
          <source>Hum Mol Genet</source>
          <year>1999</year>
          <volume>8</volume>
          <fpage>899</fpage>
          <lpage>905</lpage>
          <pub-id pub-id-type="pmid">10196380</pub-id>
          <pub-id pub-id-type="doi">10.1093/hmg/8.5.899</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adam</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Belmouden</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Binisti</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Brezin</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Valtot</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bechetoille</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dascotte</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Copin</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gomez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chaventre</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma</article-title>
          <source>Hum Mol Genet</source>
          <year>1997</year>
          <volume>6</volume>
          <fpage>2091</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">9328473</pub-id>
          <pub-id pub-id-type="doi">10.1093/hmg/6.12.2091</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>McCarty</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rosner</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Increased plasma free cortisol in ocular hypertension and open angle glaucoma</article-title>
          <source>Arch Ophthalmol</source>
          <year>1987</year>
          <volume>105</volume>
          <fpage>1060</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">2888454</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rozsival</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hampl</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Obenberger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Starka</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rehak</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Aqueous humour and plasma cortisol levels in glaucoma and cataract patients</article-title>
          <source>Curr Eye Res</source>
          <year>1981</year>
          <volume>1</volume>
          <fpage>391</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">7318492</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weinstein</surname>
              <given-names>BI</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Southren</surname>
              <given-names>AL</given-names>
            </name>
          </person-group>
          <article-title>Potentiation of glucocorticoid activity by 5 beta-dihydrocortisol: its role in glaucoma</article-title>
          <source>Science</source>
          <year>1983</year>
          <volume>222</volume>
          <fpage>172</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">6623065</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weinstein</surname>
              <given-names>BI</given-names>
            </name>
            <name>
              <surname>Iyer</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Binstock</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Hamby</surname>
              <given-names>CV</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>Moy</surname>
              <given-names>FH</given-names>
            </name>
            <name>
              <surname>Wandel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Southren</surname>
              <given-names>AL</given-names>
            </name>
          </person-group>
          <article-title>Decreased 3 alpha-hydroxysteroid dehydrogenase activity in peripheral blood lymphocytes from patients with primary open angle glaucoma</article-title>
          <source>Exp Eye Res</source>
          <year>1996</year>
          <volume>62</volume>
          <fpage>39</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">8674511</pub-id>
          <pub-id pub-id-type="doi">10.1006/exer.1996.0005</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kitazawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Horie</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The prognosis of corticosteroid-responsive individuals</article-title>
          <source>Arch Ophthalmol</source>
          <year>1981</year>
          <volume>99</volume>
          <fpage>819</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="pmid">7236083</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lewis</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Priddy</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Judd</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Kass</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kolker</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma</article-title>
          <source>Am J Ophthalmol</source>
          <year>1988</year>
          <volume>106</volume>
          <fpage>607</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">3189477</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nguyen</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Polansky</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells</article-title>
          <source>J Biol Chem</source>
          <year>1998</year>
          <volume>273</volume>
          <fpage>6341</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">9497363</pub-id>
          <pub-id pub-id-type="doi">10.1074/jbc.273.11.6341</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shepard</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fingert</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Sheffield</surname>
              <given-names>VC</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
          <article-title>Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>3173</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">11726619</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacobson</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Andrews</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shepard</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Searby</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fingert</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Hageman</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mullins</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>YH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor</article-title>
          <source>Hum Mol Genet</source>
          <year>2001</year>
          <volume>10</volume>
          <fpage>117</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">11152659</pub-id>
          <pub-id pub-id-type="doi">10.1093/hmg/10.2.117</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lutjen-Drecoll</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>May</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Polansky</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Bloemendal</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>TD</given-names>
            </name>
          </person-group>
          <article-title>Localization of the stress proteins alpha B-crystallin and trabecular meshwork inducible glucocorticoid response protein in normal and glaucomatous trabecular meshwork</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1998</year>
          <volume>39</volume>
          <fpage>517</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">9501861</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheng</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Ueda</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wentz-Hunter</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yue</surname>
              <given-names>BY</given-names>
            </name>
          </person-group>
          <article-title>Age independent expression of myocilin in the human trabecular meshwork</article-title>
          <source>Int J Mol Med</source>
          <year>2002</year>
          <volume>10</volume>
          <fpage>33</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">12060848</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fingert</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Craig</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Alward</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Snibson</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>McLaughlin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tuttle</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mackey</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Sheffield</surname>
              <given-names>VC</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>145</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">11133859</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Vollrath</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>A cellular assay distinguishes normal and mutant TIGR/myocilin protein</article-title>
          <source>Hum Mol Genet</source>
          <year>1999</year>
          <volume>8</volume>
          <fpage>2221</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">10545602</pub-id>
          <pub-id pub-id-type="doi">10.1093/hmg/8.12.2221</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clark</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Steely</surname>
              <given-names>HT</given-names>
            </name>
            <name>
              <surname>Dickerson</surname>
              <given-names>JE</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>English-Wright</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stropki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>McCartney</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shepard</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Matsushima</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>1769</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">11431441</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Polansky</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Fauss</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lutjen-Drecoll</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kurtz</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>ZD</given-names>
            </name>
            <name>
              <surname>Bloom</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>TD</given-names>
            </name>
          </person-group>
          <article-title>Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product</article-title>
          <source>Ophthalmologica</source>
          <year>1997</year>
          <volume>211</volume>
          <fpage>126</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="pmid">9176893</pub-id>
        </citation>
      </ref>
      <ref id="B19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmerman</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Lingappa</surname>
              <given-names>VR</given-names>
            </name>
            <name>
              <surname>Richards</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Rozsa</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Lichter</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Polansky</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>A trabecular meshwork glucocorticoid response (TIGR) gene mutation affects translocational processing</article-title>
          <source>Mol Vis</source>
          <year>1999</year>
          <volume>5</volume>
          <fpage>19</fpage>
          <pub-id pub-id-type="pmid">10459044</pub-id>
        </citation>
      </ref>
      <ref id="B20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caballero</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rowlette</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Borras</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Altered secretion of a TIGR/MYOC mutant lacking the olfactomedin domain</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2000</year>
          <volume>1502</volume>
          <fpage>447</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">11068187</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0925-4439(00)00068-5</pub-id>
        </citation>
      </ref>
      <ref id="B21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caballero</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Borras</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Inefficient processing of an olfactomedin-deficient myocilin mutant: potential physiological relevance to glaucoma</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2001</year>
          <volume>282</volume>
          <fpage>662</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">11401512</pub-id>
          <pub-id pub-id-type="doi">10.1006/bbrc.2001.4624</pub-id>
        </citation>
      </ref>
      <ref id="B22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Jaroszewski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ortego</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Escribano</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Coca-Prados</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Expression of the TIGR gene in the iris, ciliary body, and trabecular meshwork of the human eye</article-title>
          <source>Ophthalmic Genet</source>
          <year>2000</year>
          <volume>21</volume>
          <fpage>155</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="pmid">11035548</pub-id>
          <pub-id pub-id-type="doi">10.1076/1381-6810(200009)21:3;1-Z;FT155</pub-id>
        </citation>
      </ref>
      <ref id="B23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lorenzetti</surname>
              <given-names>OJ</given-names>
            </name>
          </person-group>
          <article-title>Effects of corticosteroids on ocular dynamics in rabbits</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>1970</year>
          <volume>175</volume>
          <fpage>763</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">5489927</pub-id>
        </citation>
      </ref>
      <ref id="B24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Knepper</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Breen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Weinstein</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Blacik</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Intraocular pressure and glycosaminoglycan distribution in the rabbit eye: effect of age and dexamethasone</article-title>
          <source>Exp Eye Res</source>
          <year>1978</year>
          <volume>27</volume>
          <fpage>567</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="pmid">720430</pub-id>
        </citation>
      </ref>
      <ref id="B25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ticho</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Lahav</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Berkowitz</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yoffe</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Ocular changes in rabbits with corticosteroid-induced ocular hypertension</article-title>
          <source>Br J Ophthalmol</source>
          <year>1979</year>
          <volume>63</volume>
          <fpage>646</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">158377</pub-id>
        </citation>
      </ref>
      <ref id="B26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hester</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Trites</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Peiffer</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Petrow</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Steroid-induced ocular hypertension in the rabbit: a model using subconjunctival injections</article-title>
          <source>J Ocul Pharmacol</source>
          <year>1987</year>
          <volume>3</volume>
          <fpage>185</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">3503913</pub-id>
        </citation>
      </ref>
      <ref id="B27">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonomi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Perfetti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Noya</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bellucci</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tomazzoli</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Experimental corticosteroid ocular hypertension in the rabbit</article-title>
          <source>Albrecht Von Graefes Arch Klin Exp Ophthalmol</source>
          <year>1978</year>
          <volume>209</volume>
          <fpage>73</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">311169</pub-id>
        </citation>
      </ref>
      <ref id="B28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kubota</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Noda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Minoshima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Asakawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kudoh</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mashima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Oguchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping</article-title>
          <source>Genomics</source>
          <year>1997</year>
          <volume>41</volume>
          <fpage>360</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">9169133</pub-id>
          <pub-id pub-id-type="doi">10.1006/geno.1997.4682</pub-id>
        </citation>
      </ref>
      <ref id="B29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fingert</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Ying</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Swiderski</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Nystuen</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Arbour</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Alward</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Sheffield</surname>
              <given-names>VC</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Characterization and comparison of the human and mouse GLC1A glaucoma genes</article-title>
          <source>Genome Res</source>
          <year>1998</year>
          <volume>8</volume>
          <fpage>377</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">9548973</pub-id>
        </citation>
      </ref>
      <ref id="B30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tomarev</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Tamm</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Characterization of the mouse Myoc/Tigr gene</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>1998</year>
          <volume>245</volume>
          <fpage>887</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">9588210</pub-id>
          <pub-id pub-id-type="doi">10.1006/bbrc.1998.8541</pub-id>
        </citation>
      </ref>
      <ref id="B31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taniguchi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kurihara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kurihara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kasai</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shirato</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Araie</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Molecular cloning of the bovine MYOC and induction of its expression in trabecular meshwork cells [In Process Citation]</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>2070</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">10892845</pub-id>
        </citation>
      </ref>
      <ref id="B32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kanno</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kubota</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Miwa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shishiba</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ozawa</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Molecular cloning and expression profile of rat myocilin [In Process Citation]</article-title>
          <source>Mol Genet Metab</source>
          <year>2000</year>
          <volume>70</volume>
          <fpage>75</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">10833334</pub-id>
          <pub-id pub-id-type="doi">10.1006/mgme.2000.2986</pub-id>
        </citation>
      </ref>
      <ref id="B33">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nielsen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Engelbrecht</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brunak</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>von Heijne</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites</article-title>
          <source>Protein Eng</source>
          <year>1997</year>
          <volume>10</volume>
          <fpage>1</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">9051728</pub-id>
          <pub-id pub-id-type="doi">10.1093/protein/10.1.1</pub-id>
        </citation>
      </ref>
      <ref id="B34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fautsch</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Characterization of myocilin-myocilin interactions</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>2324</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">11527946</pub-id>
        </citation>
      </ref>
      <ref id="B35">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wentz-Hunter</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ueda</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yue</surname>
              <given-names>BY</given-names>
            </name>
          </person-group>
          <article-title>Protein interactions with myocilin</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2002</year>
          <volume>43</volume>
          <fpage>176</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">11773029</pub-id>
        </citation>
      </ref>
      <ref id="B36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borras</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Rowlette</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Tamm</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Gottanka</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Effects of elevated intraocular pressure on outflow facility and TIGR/MYOC expression in perfused human anterior segments</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2002</year>
          <volume>43</volume>
          <fpage>33</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">11773009</pub-id>
        </citation>
      </ref>
      <ref id="B37">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Russell</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Tamm</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Grehn</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Picht</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The presence and properties of myocilin in the aqueous humor</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>983</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">11274075</pub-id>
        </citation>
      </ref>
      <ref id="B38">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>Allingham</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>TIGR/myocilin in human aqueous humor</article-title>
          <source>Exp Eye Res</source>
          <year>2000</year>
          <volume>71</volume>
          <fpage>637</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">11095916</pub-id>
          <pub-id pub-id-type="doi">10.1006/exer.2000.0920</pub-id>
        </citation>
      </ref>
      <ref id="B39">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimizu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lichter</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Higashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gottfredsdottir</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Othman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Moroi</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Rozsa</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Schertzer</surname>
              <given-names>RM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma</article-title>
          <source>Am J Ophthalmol</source>
          <year>2000</year>
          <volume>130</volume>
          <fpage>165</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="pmid">11004290</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0002-9394(00)00536-5</pub-id>
        </citation>
      </ref>
      <ref id="B40">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Imperiali</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>O'Connor</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>Effect of N-linked glycosylation on glycopeptide and glycoprotein structure</article-title>
          <source>Curr Opin Chem Biol</source>
          <year>1999</year>
          <volume>3</volume>
          <fpage>643</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">10600722</pub-id>
          <pub-id pub-id-type="doi">10.1016/S1367-5931(99)00021-6</pub-id>
        </citation>
      </ref>
      <ref id="B41">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bernard</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Olden</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Carbohydrates selectively protect a specific domain of fibronectin against proteases</article-title>
          <source>J Biol Chem</source>
          <year>1982</year>
          <volume>257</volume>
          <fpage>8549</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="pmid">7045125</pub-id>
        </citation>
      </ref>
      <ref id="B42">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Savinova</surname>
              <given-names>OV</given-names>
            </name>
            <name>
              <surname>Reedy</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lun</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Gan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Tomarev</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>John</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function</article-title>
          <source>Mol Cell Biol</source>
          <year>2001</year>
          <volume>21</volume>
          <fpage>7707</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">11604506</pub-id>
          <pub-id pub-id-type="doi">10.1128/MCB.21.22.7707-7713.2001</pub-id>
        </citation>
      </ref>
      <ref id="B43">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wiggs</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Vollrath</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Molecular and clinical evaluation of a patient hemizygous for TIGR/MYOC</article-title>
          <source>Arch Ophthalmol</source>
          <year>2001</year>
          <volume>119</volume>
          <fpage>1674</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">11709019</pub-id>
        </citation>
      </ref>
      <ref id="B44">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lam</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Chua</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Baum</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Choy</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Pang</surname>
              <given-names>CP</given-names>
            </name>
          </person-group>
          <article-title>Truncations in the TIGR gene in individuals with and without primary open-angle glaucoma</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>1386</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">10798654</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>